I'm not sure if information on this study has already been posted.
I thought it sounded promising.
Sue
http://www.cancernet...e=1&ts=19032014
Posted 25 April 2014 - 11:59 AM
I'm not sure if information on this study has already been posted.
I thought it sounded promising.
Sue
http://www.cancernet...e=1&ts=19032014
Dx April 2013, FISH 62, BMB not enough for PCR test; put on Gleevec 400;
August 2013, FISH 8.7;
Oct 2013, FISH 5.6
Stopped Gleevec Nov 2013 for 6 weeks due to terrible side effects; Jan 2014 started Sprycel 50mg;
Feb, 2014 PCR 6.8
May,2014 PCR .149
Aug, 2014 PCR .015
Nov. 2014 PCRU
March, 2016 went down to 40mg Sprycel
Oct. 2016 stopped Sprycel for a couple weeks due to concern about shortness of breath. Echo showed mild PAH.
Nov 1 2016 resumed Sprycel 20 mg daily
Dec 2016 PCRU
March 2017 PCR 0.020
May 2017 PCRU
Sept 2017 PCRU
Dec 2017 PCRU
Posted 25 April 2014 - 08:09 PM
It is just supposed to be a more sensitive PCR (down to .0032% IS, which is 4.5 log reduction) to determine if the patient is truly in PCRU status. Not sure that is much improvement, but maybe a little. By the way, Dr Brian Druker is the founder of the company MolecularMD which is developing this PCR test process.
Posted 25 April 2014 - 08:25 PM
Thanks for the information, Trey.
The fact that Dr. Druker is involved seems like a hopeful sign.
Sue
Dx April 2013, FISH 62, BMB not enough for PCR test; put on Gleevec 400;
August 2013, FISH 8.7;
Oct 2013, FISH 5.6
Stopped Gleevec Nov 2013 for 6 weeks due to terrible side effects; Jan 2014 started Sprycel 50mg;
Feb, 2014 PCR 6.8
May,2014 PCR .149
Aug, 2014 PCR .015
Nov. 2014 PCRU
March, 2016 went down to 40mg Sprycel
Oct. 2016 stopped Sprycel for a couple weeks due to concern about shortness of breath. Echo showed mild PAH.
Nov 1 2016 resumed Sprycel 20 mg daily
Dec 2016 PCRU
March 2017 PCR 0.020
May 2017 PCRU
Sept 2017 PCRU
Dec 2017 PCRU
0 members, 1 guests, 0 anonymous users